Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 5, 2008, Pages

  Du Toit, Eugene F ^a   Smith, Wayne ^a   Muller, Christo ^a   Strijdom, Hans ^a   Stouthammer, Bernadette ^a   Woodiwiss, Angela J ^b   Norton, Gavin R ^b   Lochner, Amanda ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cardiac function; Insulin resistance; Myocardial infarction

Indexed keywords

FATTY ACID; INSULIN; TRIACYLGLYCEROL; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; FATTY ACID BLOOD LEVEL; GLYCOLYSIS; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DISEASE MODEL; HEART MUSCLE; HEART OUTPUT; HEART VENTRICLE REMODELING; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; CARDIAC OUTPUT; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; GLYCOLYSIS; INSULIN; INSULIN RESISTANCE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NOREPINEPHRINE; OBESITY; PREDIABETIC STATE; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR REMODELING;

EID: 44949263076     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00481.2007     Document Type: Article

References (38)

1. Barr RL, Lopaschuk GD. Direct measurement of energy metabolism in the isolated working rat heart. J Pharmacol Toxicol Methods 38: 11-17, 1997.
2. Belke D, Larsen T, Lopaschuk G, Severson DL. Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol Regul Integr Comp Physiol 277: R1210-R1217, 1999.
3. Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simmoons M, Armstrong PW, Topol EJ, Califf RM. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. Circulation 95: 2508-2516, 1997.
4. Braunwald E, Sobel BE. Coronary blood flow and myocardial ischemia. In: Heart Disease: A Textbook of Cardiovascular Medicine, edited by Braunwald E. Philadelphia, PA: Saunders, 1988, p. 1191-1221.
5. Cordain L, Eaton SB, Sebastian A, Mann N, Lindenberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the western diet: health implications for the 21st century. Am J Clin Nutr 81: 341-354, 2005.
6. + exchanger in reperfusion stunning in isolated perfused rat heart. J Cardiovasc Pharmacol 22: 877-883, 1993.
7. Du Toit EF, Nabben M, Lochner A. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischemic/reperfusion injury. Basic Res Cardiol 100: 346-354, 2005.
8. Du Toit EF, Rossouw E, Salie R, Opie LH, Lochner A. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model. Cardiovasc Drugs Ther 19: 23-31, 2005.
9. Eisenstein EL, McGuire DK, Bhapkar MV, Kristinsson A, Hochman JS, Kong DF, Califf RM, Van de Werf F, Yancy WS, Newby K. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Am J Med 118: 981-990, 2005.
10. Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acids attenuate insulin regulation of 5-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ Res 99: 61-68, 2006.
11. Ganhao MF, Hattingh J, Hurwitz ML, Pitts NI. Evaluation of a simple plasma catecholamine extraction procedure prior to high-performance liquid chromatography and electrochemical detection. J Chromatogr 564: 55-66, 1991.
12. Gonsolin D, Couturier K, Garait B, Rondel S, Novel-Chate V, Peltier S, Faure P, Gachon P, Boirie Y, Keriel C, Favier R, Pepe S, Demaison L, Leverve X. High dietary sucrose triggers hyperinsulinemia, increases myocardial β-oxidation, reduces glycolytic flux and delays post-ischaemic contractile recovery. Mol Cell Biochem 295: 217-228, 2007.
13. Hafstad AD, Khalid AM, How OJ, Larsen TS, Aasum E. Glucose and insulin improve cardiac efficiency and post-ischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Am J Physiol Endocrinol Metab 292: E1288-E1294, 2007.
14. Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen T. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14: 615-623, 2000.
15. Jonassen AK, Sack M, Mjos OD, Yellon DM. Myocardial protection by insulin in reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signalling. Circ Res 89: 1191-1198, 2001.
16. Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 292: R920-R926, 2007.
17. Kennedy LM, Dickstein K, Anker SD, Kristianson K, Willenheimer R; OPTIMAAL Study Group. The prognostic importance of body mass index after complicated myocardial infarction. J Am Coll Cardiol 45: 154-164, 2005.
18. Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C, Kober L; TRACE study group. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol 98: 123-131, 2005.
19. Liedtke AJ, De Maison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 62: 535-542, 1988.
20. Lopaschuk GD, Barr RL. Measurement of fatty acid and carbohydrate metabolism in the isolated working rat heart. Mol Cell Biochem 172: 137-147, 1997.
21. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischaemia. Circ Res 66: 546-553, 1990.
22. Lopez-Jimenez F, Jacobsen SJ, Reeder GS, Weston SA, Meverden RA, Roger VL. Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction. Chest 125: 1205-1212, 2004.
23. Lorber R, Gidding SS, Daviglu ML, Colangelo LA, Liu K, Gardin JM. Influence of systolic blood pressure and body mass index on left ventricular structure in healthy African-American and white adults: The CARDIA Study. J Am Coll Cardiol 41: 955-960, 2003.
24. Morel S, Berthonneche C, Tanguy S, Toufektsian MC, Foulon T, de Lorgeril M, de Leiris J, Boucher F. Insulin resistance modifies plasma fatty acid distribution and decreases cardiac tolerance to in vivo ischaemia/ reperfusion in rats. Clin Exp Pharmacol Physiol 30: 446-451, 2003.
25. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Gualgliumi G, Stuckey T, Turco M, Negoita M, Lansky A, Mehran R. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 151: 168-175, 2006.
26. Norton GR, Woodiwiss AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP, Meyer TE. Heart failure in pressure overload hypertrophy: the relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol 39: 664-671, 2002.
27. Pickavance L, Tadayyon M, Widdowson PS, Buckingham RE, Wilding JP. Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution. Br J Pharmacol 128: 1570-1576, 1999.
28. Rana JS, Mukamal KJ, Morgan JP, Muller JE, Mittleman MA. Obesity and the risk of death after acute myocardial infarction. Am Heart J 147: 841-846, 2004.
29. Rea TD, Heckbert SR, Kaplan RC, Psaty BM, Smith NL, Lemaitre RN, Lin D. Body mass index and the risk of recurrent coronary events following acute myocardial infarction. Am J Cardiol 88: 467-472, 2001.
30. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108: 560-565, 2003.
31. Thim T, Bentzon JF, Kristiansen SB, Simonsen U, Andersen HL, Wassermann K, Falk E. Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome. Clin Sci (Lond) 110: 665-671, 2006.
32. True LD. Morphometric applications in anatomic pathology. Hum Pathol 27: 450-467, 1996.
33. Veliotes DG, Woodiwiss AJ, Deftereos DA, Gray D, Osadchii O, Norton GR. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Hypertension 45: 914-920, 2005.
34. Wambolt RB, Henning SL, Englisg DR, Bondy GP, Allard MF. Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion. J Mol Cell Cardiol 29: 939-948, 1997.
35. Yancy WS Jr, Plsen MK, Curtis LH, Schulman KA, Cuffe MS, Oddone EZ. Variations in coronary procedure utilization depending on body mass index. Arch Intern Med 27: 1381-1387, 2005.
36. Yue TL, Bao W, Gu JL, Cui J, Tao L, Ma XL, Ohlstein EH, Jucker BM. Rosiglitazone treatment in Zucker diabetic fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/ reperfusion-induced myocardial injury. Diabetes 54: 554-562, 2005.
37. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366: 1640-1649, 2005.
38. Zhang HF, Fan Q, Qian XX, Lopez BL, Christopher TA, Ma XL, Gao F. Role of insulin in the anti-apoptotic effects of glucose-insulin-potassium in rabbits with acute myocardial ischaemia and reperfusion. Apoptosis 9: 777-783, 2004.